US Edition
News from International Accounting Bulletin
We’ve assigned a media bias rating of unknown to International Accounting Bulletin. You can read more about our methodology here.
Information about International Accounting Bulletin
Where is International Accounting Bulletin located?International Accounting Bulletin's WebsiteMedia Bias Ratings
Do you disagree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top International Accounting Bulletin News
Goldman Sachs · OntarioSAN FRANCISCO, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Fieldguide, a leading agentic AI-native platform for audit and advisory, today announced a $75 million Series C led by Growth Equity at Goldman Sachs Alternatives, with participation from new investor, Geodesic, and…See the Story
Fieldguide Raises $75M Series C From Goldman Sachs to Help Audit and Advisory Firms Grow with ...
56% Left coverage: 9 sources
Donald TrumpSenator Thom Tillis, R-N.C., just threw down the gauntlet, promising he will oppose every single Federal Reserve nominee proposed by the Trump administration until the Department of Justice completely ends its probe into current Fed Chairman Jerome Powell. Tillis, who has a history of clashing with the administration and isn’t seeking re-election, announced via X that he would specifically block the confirmation of Kevin Warsh. This isn’t about …See the Story
GOP Senator Promises to Block All Trump Federal Reserve Nominees After ‘Outrageous’ DOJ Probe Into Jerome Powell
62% Right coverage: 8 sources
Private Equity · United KingdomThe proposed sale of UK accountancy practice Xeinadin has been paused after bids fell short of the more than £1bn ($1.36bn) valuation sought by its private equity owner, the Financial Times (FT) reported. Exponent, the UK buyout firm that invested in Xeinadin roughly four years ago, brought in Evercore last summer to run a competitive auction. People familiar with the talks told the publication that interest did not translate into offers at the …See the Story
